Kintara Therapeutics, Inc. Profile Avatar - Palmy Investing

Kintara Therapeutics, Inc.

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targe…

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Kintara Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Kintara Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Kintara Therapeutics, Inc..

End of KTRA's Analysis
CIK: 1498382 CUSIP: 49720K101 ISIN: US49720K2006 LEI: - UEI: -
Secondary Listings
KTRA has no secondary listings inside our databases.